Abstract
Donated blood is a limited resource. The impact of variant Creutzfeldt Jakob Disease is a potential threat to the blood supply. As 10% of the red cells issued to hospitals are used in orthopaedic surgery, elective orthopaedic surgery may well suffer disruption if the supply of red cells is compromised in the future. A survey of transfusion practice confirmed wide variation in practice in elective joint replacement survey. It is, therefore, essential that orthopaedic surgeons and transfusion specialists collaborate to ensure that blood is used appropriately. Current measures to conserve allogeneic blood in elective joint replacement surgery will be reviewed. The extent to which these strategies are used in hospitals and their efficacy will be discussed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
